Clinical trials
Completed Kidney Diseases trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Tanabe Pharma Corporation | 2 |
| Anthera Pharmaceuticals | 1 |
| HI-Bio, A Biogen Company | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Sankyo Pharma Gmbh | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 9 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetic Nephropathies | 3 |
| Renal Insufficiency, Chronic | 3 |
| Glomerulonephritis, IGA | 2 |
| Urologic Diseases | 2 |
| Autoimmune Diseases | 1 |
| Carcinoma, Renal Cell | 1 |
| Glomerulonephritis | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.